UMIN ID: UMIN000000622
Registered date:01/03/2007
Heart Failure management by COmbination of STatin and ARB
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Chronic heart failure |
| Date of first enrollment | 2003/08/01 |
| Target sample size | 40 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | ARB group ARB+STATIN group |
Outcome(s)
| Primary Outcome | Hositalization and death caused by heart failure Left ventricular ejection fraction (measured by echocardiography) |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 80years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | The patient who is improper of this study. |
Related Information
| Primary Sponsor | Department of Cardiovascular Medicine, Tokyo Medical and Dental University |
|---|---|
| Secondary Sponsor | Department of Cardiovascular Medicine, Akita University |
| Source(s) of Monetary Support | BANYU Pharmaceuticals Co. Ltd. |
| Secondary ID(s) |
Contact
| public contact | |
| Name | |
| Address | Japan |
| Telephone | |
| Affiliation | Tokyo Medical and Dental University Department of Cardiovascular Medicine |
| scientific contact | |
| Name | Mitsuaki Isobe |
| Address | yushima 1-5-45, Bunkyo-ku, Tokyo Japan |
| Telephone | |
| Affiliation | Tokyo Medical and Dental University Department of Cardiovascular Medicine |